He is currently working as Assistant Professor, his research includes how IGFBP-2 supplementation and MSC co-culture supported modest but long-term engraftment of donor cells with minimal GVHD symptoms, and how suboptimal outcome with regards to neutrophil engrDÑment, primarily due to complicated patient disease status at transplantation and low CD34+ cell infusion dosage which contributed to high mortality and premature trial discontinuation.